BLFS
Price
$23.78
Change
+$0.95 (+4.16%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
810.87M
35 days until earnings call
FEMY
Price
$1.30
Change
+$0.07 (+5.69%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
33.56M
35 days until earnings call
Ad is loading...

BLFS vs FEMY

Header iconBLFS vs FEMY Comparison
Open Charts BLFS vs FEMYBanner chart's image
BioLife Solutions
Price$23.78
Change+$0.95 (+4.16%)
Volume$6.31K
Capitalization810.87M
Femasys
Price$1.30
Change+$0.07 (+5.69%)
Volume$1.34K
Capitalization33.56M
BLFS vs FEMY Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. FEMY commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a StrongBuy and FEMY is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (BLFS: $22.83 vs. FEMY: $1.23)
Brand notoriety: BLFS and FEMY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 224% vs. FEMY: 30%
Market capitalization -- BLFS: $810.87M vs. FEMY: $33.56M
BLFS [@Medical Specialties] is valued at $810.87M. FEMY’s [@Medical Specialties] market capitalization is $33.56M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileFEMY’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • FEMY’s FA Score: 0 green, 5 red.
According to our system of comparison, BLFS is a better buy in the long-term than FEMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 3 TA indicator(s) are bullish while FEMY’s TA Score has 5 bullish TA indicator(s).

  • BLFS’s TA Score: 3 bullish, 7 bearish.
  • FEMY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, FEMY is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Medical Specialties) experienced а -11.58% price change this week, while FEMY (@Medical Specialties) price change was -23.13% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.75%. For the same industry, the average monthly price growth was +3.84%, and the average quarterly price growth was +3.01%.

Reported Earning Dates

BLFS is expected to report earnings on May 08, 2025.

FEMY is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Medical Specialties (-1.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($811M) has a higher market cap than FEMY($33.6M). BLFS has higher P/E ratio than FEMY: BLFS (238.10) vs FEMY (4.17). FEMY YTD gains are higher at: 11.818 vs. BLFS (-12.057). FEMY has higher annual earnings (EBITDA): -11.83M vs. BLFS (-45.24M). BLFS has more cash in the bank: 51.7M vs. FEMY (8.69M). FEMY has less debt than BLFS: FEMY (2.86M) vs BLFS (42.7M). BLFS has higher revenues than FEMY: BLFS (143M) vs FEMY (1.09M).
BLFSFEMYBLFS / FEMY
Capitalization811M33.6M2,414%
EBITDA-45.24M-11.83M382%
Gain YTD-12.05711.818-102%
P/E Ratio238.104.175,714%
Revenue143M1.09M13,083%
Total Cash51.7M8.69M595%
Total Debt42.7M2.86M1,491%
FUNDAMENTALS RATINGS
BLFS: Fundamental Ratings
BLFS
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLFSFEMY
RSI
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 28 days ago
80%
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDPAX15.640.04
+0.26%
Janus Henderson Mid Cap Value A
LSHAX36.76N/A
N/A
Kinetics Spin-Off and Corp Rest Adv A
CEKYX13.51N/A
N/A
Columbia Emerging Markets Inst3
WLCGX47.18N/A
N/A
Wilshire Large Company Growth Instl
FSGGX15.31N/A
N/A
Fidelity Global ex US Index

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
-0.04%
RGEN - BLFS
49%
Loosely correlated
+0.99%
VCYT - BLFS
43%
Loosely correlated
-0.30%
QTRX - BLFS
42%
Loosely correlated
+2.38%
NEO - BLFS
40%
Loosely correlated
-1.48%
RDNT - BLFS
40%
Loosely correlated
+1.81%
More

FEMY and

Correlation & Price change

A.I.dvisor tells us that FEMY and OM have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FEMY and OM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEMY
1D Price
Change %
FEMY100%
-1.60%
OM - FEMY
27%
Poorly correlated
-1.36%
BNGO - FEMY
26%
Poorly correlated
+11.11%
NYXH - FEMY
26%
Poorly correlated
-1.58%
CUTRQ - FEMY
25%
Poorly correlated
N/A
BLFS - FEMY
25%
Poorly correlated
-0.04%
More